AbbVie Inc (ABBV) Price Targets From Analysts
Use the tables below to see what analysts covering AbbVie Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 20 | $127 | $97 | $112.05 | $105.9 | 5.81% |
The Trend in the Analyst Price Target
Over the past 136 days, ABBV's average price target has gone up $4.12.
Over the past 175 days, ABBV's average upside potential has been 13.26%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-06-08 | 14 | 122 | 70 | 98.71 | 94.59 | 4.36% |
| 2020-06-09 | 15 | 122 | 70 | 100.40 | 96.17 | 4.4% |
| 2020-06-16 | 15 | 122 | 70 | 101.27 | 96.06 | 5.42% |
| 2020-06-24 | 15 | 125 | 70 | 104.53 | 95.14 | 9.87% |
| 2020-07-02 | 14 | 125 | 91 | 107.64 | 98.87 | 8.87% |
| 2020-07-02 | 14 | 125 | 91 | 107.64 | 98.88 | 8.86% |
| 2020-07-17 | 14 | 125 | 93 | 107.93 | 100.83 | 7.04% |
| 2020-07-22 | 14 | 125 | 93 | 107.93 | 97.70 | 10.47% |
| 2020-08-03 | 14 | 127 | 95 | 110.14 | 95.94 | 14.8% |
| 2020-08-12 | 15 | 127 | 95 | 109.47 | 95.51 | 14.62% |
| 2020-08-22 | 15 | 127 | 96 | 110.33 | 94.86 | 16.31% |
| 2020-08-23 | 15 | 127 | 96 | 110.33 | 94.86 | 16.31% |
| 2020-09-01 | 16 | 127 | 96 | 110.00 | 92.24 | 19.25% |
| 2020-09-10 | 16 | 127 | 96 | 110.00 | 89.65 | 22.7% |
| 2020-09-30 | 17 | 127 | 96 | 109.29 | 87.59 | 24.77% |
| 2020-10-21 | 18 | 127 | 96 | 109.61 | 82.89 | 32.24% |
| 2020-11-10 | 19 | 127 | 97 | 110.84 | 98.87 | 12.11% |
| 2020-11-17 | 20 | 127 | 97 | 111.45 | 99.21 | 12.34% |
| 2020-11-30 | 20 | 127 | 97 | 112.05 | 104.58 | 7.14% |
ABBV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
The Trend in the Broker Recommendations
list("500 - Internal server error")
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ABBV has a greater number of analysts covering the stock than 93.63% of all US stocks.
- The average analyst price target of ABBV is higher than 93.12% of Pharmaceutical Products stocks.
- AbbVie Inc's upside potential (average analyst target price relative to current price) is higher than 8.64% of Pharmaceutical Products stocks.
- ABBV has a less variance in analysts' estimates than 75.38% of stocks in the large market cap category.
What is the outlook for ABBV? Use POWR Ratings for clearer insight into price direction.